Hepatocellular carcinoma (HCC) is the most prevalent type of malignant liver disease
worldwide. Molecular changes in HCC collectively contribute to Wnt/β-catenin, as a tumor …

Hepatocellular carcinoma (HCC) is the subtype of liver cancer with the highest incidence,
which is a heterogeneous malignancy with increasing incidence rate and high mortality. For …

This study aimed to select the feature genes of hepatocellular carcinoma (HCC) with the
Fisher score algorithm and to identify hub genes with the Maximal Clique Centrality (MCC) …

Hepatocellular carcinoma (HCC) is by far the most common histological subtype of primary
liver cancer. HCC often originates from chronic liver injuries and inflammation, subsequently …

The increasing cancer incidence has certified oncological management as one of the most
critical challenges for the coming decades. New anticancer strategies are still needed …

Objective: Hepatocellular carcinoma (HCC) is the most common liver malignancy. Sorafenib
is the first-line systemic treatment for advanced HCCs. However, due to safety concerns …

Hepatocellular carcinoma (HCC) is the fifth most commonly diagnosed cancer and the
second most common cause of cancer‐related death worldwide. Sorafenib (Sora) is used as …

Recent studies have shown that cancer stem cells (CSCs) are involved in the occurrence
and development of hepatocellular carcinoma (HCC). However, potential mechanisms for …

We thank Li's comments and interest in our recent article [1]. After careful authentication of
the HepG2 cell line used in our study, we believe the raised concerns regarding possible …

Background Hepatocellular carcinoma (HCC) is the fifth most diagnosed cancer and the
second leading cause of cancer‐related deaths worldwide. Sorafenib is the standard …